More specifically, there were patients with CIDP and Guillain–Barré syndrome (GBS) that were positive for anti-CASPR1 antibodies and negative for anti-CNTN1 or NF155 antibodies. Here, CNTN1 is linked to chronic inflammatory demyelinating polyradiculoneuropathy.